Company with sales of around 600 crores (has grown 20 to 30 percent per annum).
Excellent outlook
EPS or around 18 to 20
Bulk drug manufacturer
Trading at PE of 4.0 (industry PE of 21.0)

I feel its reasonable to consider a fair PE of 8 for this stock (looking at growth based on historical data)

Contract research is gaining strong hold for such companies in india and Ind-Swift has been strongly moving forward (I know that the stock has not performed and hence it gives us an opportunity )

I strongly feel if retail investors put their eye on it and grab if to hold for one years time it will for sure reach 120 within next 3 months.
As it looks to be operator driven, you can actually beat the operators

Just simply buy and hold for six months .................

Its a sure shot fundamental buy, don`t miss this opportunity.

I am sure it will shoot up once the new of acquisition comes into the market, Slow and steady accumulation is anyways going on.

Actually if you see Total Debt on Books vis a vis its equity and networth, you can get answers to its low valuations. Good scrip. Have been holding it for long term.